The FDA approved Bizengri for adults with advanced, unresectable, or metastatic NRG1 fusion-positive cholangiocarcinoma after prior systemic therapy, providing a new targeted option for an ultra-rare and...
Test your knowledge with this quick quiz based on new JAMA research using objective smartphone tracking to reveal patterns of in-school screen use and the demographic factors associated with higher use.
...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
Gracyn Allan, BS; Rachel Anderson, BS; Gelan Shamloul, DO; Thomas N. Helm, MD
A 19-year-old collegiate athlete presented with progressive darkening of the lips and oral mucosa beginning in the summer of 2022. The pigmentation, which began on her lips, extended over time to her...
A 21-year-old previously healthy woman presented to the emergency room with a progressive rash on her right leg and was found to be febrile and hypotensive.
